SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-23-076238
Filing Date
2023-09-13
Accepted
2023-09-13 08:47:06
Documents
14
Period of Report
2023-09-11
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea185123-8k_oramed.htm   iXBRL 8-K 42914
2 SECURITIES TRANSFER TERM SHEET, DATED SEPTEMBER 11, 2023 AMONG SCILEX HOLDING CO ea185123ex99-1_oramed.htm EX-99.1 126770
3 NOTE TERM SHEET, DATED SEPTEMBER 11, 2023 AMONG THE COMPANY, SCILEX HOLDING COMP ea185123ex99-2_oramed.htm EX-99.2 75838
  Complete submission text file 0001213900-23-076238.txt   474471

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE ormp-20230911.xsd EX-101.SCH 3009
5 XBRL LABEL FILE ormp-20230911_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE ormp-20230911_pre.xml EX-101.PRE 22355
8 EXTRACTED XBRL INSTANCE DOCUMENT ea185123-8k_oramed_htm.xml XML 3320
Mailing Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036
Business Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036 646-844-1164
ORAMED PHARMACEUTICALS INC. (Filer) CIK: 0001176309 (see all company filings)

IRS No.: 980376008 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35813 | Film No.: 231251680
SIC: 2834 Pharmaceutical Preparations